High throughput screening

CAR-T cells attack cancer cells
#Cancer research #CAR-T #Cell and gene therapy #Cell therapy #High throughput screening #Immunotherapy #T cell activation

Watch now: Improve cell therapies with high-throughput CAR libraries

CAR-T cell therapies are a promising approach for treating solid tumours. But identifying appropriate T-cell receptor (TCR) domains that exclusively target tumour antigens remains a challenge. Toxicity, tumour activation, and tumour persistence are significant challenges to using CAR-T cell therapies for solid tumours. In this new on-demand… Read More

Webinar date:
Brought to you by Twist Bioscience
#Editor's Choice #News

CAR-T cells attack cancer cells
#Cancer research #CAR-T #Cell and gene therapy #Cell therapy #High throughput screening #Immunotherapy #T cell activation

Improving cell therapies with high-throughput CAR libraries

CAR-T cell therapies are a promising approach for treating solid tumours. But identifying appropriate T-cell receptor (TCR) domains that exclusively target tumour antigens remains a challenge. Toxicity, tumour activation, and tumour persistence are significant challenges to using CAR-T cell therapies for solid tumours. In this webinar, Twist Bioscience’s CSO, Aaron… Read More

Webinar date:
Brought to you by Twist Bioscience
#Webinars

Drug screening in laboratory
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Collaboration #Drug targets #High throughput screening #Partnership #Phenotyping #PhoreMost #ThinkCyte

New research collaboration to advance AI based drug discovery

PhoreMost and ThinkCyte have entered a strategic research partnership aimed at advancing modern phenotypic drug screening using artificial intelligence (AI).  The partnership leverages both companies’ technologies in high-throughput drug discovery, PhoreMost’s phenotypic screening platform, SITESEEKER, and ThinkCyte’s AI-driven cell characterisation and sorting platform, Ghost Cytometry. … Read More

#News

Enzymes
#Biologics / Biotechnology #Collaboration #Enzymes #High throughput screening #Partnership #Synthetic biology

Partnership hopes to accelerate protein discovery

GenScript Biotech, a provider of life-science research tools and services, is partnering with Allozymes, a Singapore-based biotech startup, with aims to accelerate the enzyme discovery and development process.  In the partnership, GenScript will provide the mutant libraries construction and expression, while Allozymes will provide ultra-high-throughput screening for… Read More

#News

#Drug discovery #High throughput screening #Mass spectrometry / NMR

Transforming high-throughput screening with mass spectrometry

Arndt Asperger, Senior Applications Scientist, Bruker Daltonics and Meike Hamester, Vice President Label-Free Technologies, Bruker Daltonics, examine how challenges in mass spectrometry for high-throughput screening can be overcome using a label-free approach.   Mass spectrometry is inherently appealing for high-throughput screening (HTS), because it avoids certain drawbacks of label-based assays, but long-standing… Read More

#Exclusive Content

#Cell culture #High throughput screening #Pharma #SLAS Europe

Anticipating SLAS Europe 2022: Reflections and expectations

Jeremy Simpson is a keynote speaker for SLAS Europe 2022 and shares with Megan Thomas what excites him about this year’s programme and what he hopes the conference will cover, including approaches for standardisation in 3D cell models and new applications of data science. The day-to-day Simpson describes his set… Read More

#Exclusive Content

#High throughput screening #Lab automation #Thermo Fisher Scientific

Sample handling system relieves sample processing bottleneck  

Thermo Fisher Scientific has launched a new automated sample transfer system that can process 192 saliva or nasopharyngeal samples from tube to well in 40 minutes to address a pain point and accelerate sample processing workflow.   The ‘pain point’  Scientific research in areas such as… Read More

#News

#Biotechnology #Case study #Drug discovery #High throughput screening

Case study: Discover an innovative CRO offering unique solutions

Drug discovery contract research organizations (CROs) offer an established infrastructure and experience that offers promising paths forward for various research projects. However, partnering with a CRO also presents key challenges, and companies should consider three questions: How long until data is delivered? Will the quality of the data instill confidence… Read More

#News

#Assays #Drug discovery #High throughput screening #Technology

Case study outlines how to create more therapeutic opportunity

Pairing the right small molecule library with innovative high-throughput screening creates more therapeutic opportunity, this SAMDI Tech case study shows.  Finding an encouraging drug lead that selectively engages a target of interest is the result of several matches that lead to successful drug discovery programmes, including: … Read More

#News

#Bioscience #Covid-19 #High throughput screening

Twist Bioscience antibody shows potent binding to SARS-CoV-2 strains 

Twist Bioscience has reported that its internally-discovered antibody candidate TB202-3 (CoVIC-094) demonstrated potent binding to diverse SARS-CoV-2 variant mutations, including strains with the E484K, N501Y, D614G, Y453F and K417N mutations in pseudovirus assays, indicating this therapeutic antibody may be effective in treating many strains of Covid-19.   The Coronavirus Immunotherapy… Read More

#News

#High throughput screening #Podcast

Podcast: Enhancing the role of multiplexing in HTS

The latest sponsored DDW Sitting Down With podcast features Paul Wylie, Director of Multiplex at Abcam looking at enhancing the role of multiplexing in high-throughput screening.  Among the topics Lu Rahman will be discussing with Wylie will be the key challenges scientists face with biomarker and… Read More

#News #Trending News

#Biosciences #Clinical trials #Drug delivery #Drug discovery #High throughput screening #Therapeutics

Mini-library approach delivers an arsenal in drug development pipeline

Listen to this article on the DDW Podcast: Dr. Naganna Nimishetti, Chief of the Small Molecule Drug Discovery Division (SMDD) and Dr. Dun Yang, CEO/CSO of Anticancer Bioscience, a precision therapeutics company headquartered in Chengdu, China, explain how the company is identifying bioactive hits using libraries of less than 100 compounds. Read More

#Editor's Choice #Exclusive Content #News

#Biomarkers #Drug delivery #Drug discovery #Drug screening #High throughput screening #Webinar

Webinar: Enabling biomarker discovery and screening

Multiplex assays allow researchers to measure multiple biomarkers simultaneously, offering the advantage of harvesting more insightful data to inform better decision-making, accelerate research, and increase the probability of discovery. Enabling biomarker discovery and screening with FirePlex Multiplexed Assays features the expertise of Dr Paul Wylie. In this webinar with… Read More

#News

#Drug development #Drug discovery #Drug screening #High throughput screening

What will this NIGMS grant mean for combatting rare diseases?

Sinopia Biosciences has been awarded a grant from the National Institute of General Medical Sciences (NIGMS), as part of the National Institutes of Health, to further develop and validate their proprietary metabolomics-based high-throughput screening (HTS) platform with an initial focus on rare diseases. To date, Sinopia has received nearly $8… Read More

#News

#Biotechnology #Drug discovery #High throughput screening #Whitepaper

High-throughput screening for small molecule drug discovery

High-throughput screening remains one of the most powerful, unbiased approaches for small molecule drug discovery. In this whitepaper, “Disrupting Drug Discovery From Assay Development to Lead Compound”, SAMDI Tech CSO, Zack Gurard-Levin, discusses the important aspects to consider when choosing the right methodology for drug discovery. The whitepaper covers traditional… Read More

#News

#Anti-viral drug screening #Assay validation #Automated workflows #Drug screening #High throughput screening #Immunology / Virology & Vaccines #Microplate readers #SARS-CoV-2

Webinar: Improving work rate, productivity and getting to market faster

We know there are operational vulnerabilities in pharmaceutical research and in the drug discovery pipeline. Bringing new drugs to the market is slow and expensive, with high costs, failure rates and cycle times. With low reproducibility and inefficient processes delaying the path to approval, the current pandemic is prompting a… Read More

#News